DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

References

Leiter LA, Bain SC, Hramiak I. et al.
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.

Cardiovasc Diabetol 2019;
18: 73

Download Bibliographical Data

Access:
Access: